Should I Buy MFC? MFC 2026 Analysis

Should You Buy Manulife Financial Corp (MFC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

38.040

1 Day change

1.79%

52 Week Range

38.720

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: short-term momentum is weakening (MACD histogram negative and expanding) while price is sitting near the pivot (~37.59), so odds favor chop/down before a cleaner setup.
Medium-term trend is still constructive (SMA_5 > SMA_20 > SMA_200), so this is more of a hold/accumulate-on-dip name than a chase-at-market name today.
Options positioning is mildly bullish (put/call ratios < 1), but implied volatility is elevated (IV percentile ~81.7), implying higher event/uncertainty pricing into earnings.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the broader trend remains up.
Momentum: MACD histogram at -0.036 and negatively expanding = short-term momentum deterioration / risk of near-term pullback.
RSI(6): 46.63 (neutral) = no oversold bounce signal and no strong bullish momentum.
Key levels: Pivot 37.586 (price ~37.51 slightly below pivot). Support S1 36.665 then S2 36.097. Resistance R1 38.507 then R2 39.075.
Pattern-based odds: modeled outlook shows ~+1.31% next week but ~-2.4% next month, reinforcing “not a great immediate buy” timing.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put/Call ratios below 1 (OI 0.61; volume 0.54) lean bullish (more call interest/flow than puts).
Activity: Today’s option volume 557 vs 30-day average (reported) at ~452.85% = unusually heavy attention.
Volatility: 30D IV 27.49 vs historical vol 17.94 and IV percentile 81.67 = options are relatively expensive and pricing higher uncertainty.
Skew/positioning: Total OI 7,445 with calls (4,628) > puts (2,817) supports a mildly risk-on stance, but elevated IV suggests traders are paying up for protection/convexity into catalysts.

Technical Summary

Sell

Buy

Positive Catalysts

- Upcoming earnings: QDEC 2025 earnings on 2026-02-12 after hours (a clear near-term catalyst).
- Analyst tone improving: multiple price target raises and at least one notable upgrade (CIBC to Outperformer) support sentiment.
- Business momentum signs (from prior coverage notes): strong core insurance results and Asia sales growth referenced by analysts in recent updates.
- Broader trend still positive per moving averages, which can attract trend-following flows if support holds.

Neutral/Negative Catalysts

- Technical momentum is currently negative (MACD weakening), increasing odds of a dip toward 36.67/36.10 support before a better entry.
- Macro/industry headwinds cited by analysts: spread compression risk, technology spend, and sensitivity to interest-rate moves.
- No supportive news flow in the past week (no fresh positive catalyst to reverse short-term momentum).
- Short-horizon market backdrop is risk-off (S&P 500 -1.04% today), which can pressure financials.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 10.124B, +2.58% YoY (steady top-line growth).
Net income: 1.741B, -2.36% YoY (profitability slightly softer YoY).
EPS: 1.02, +2.00% YoY (earnings per share modestly improving despite net income dip).
Overall: mixed-but-stable quarter—growth is present, but not strong enough to override the current short-term technical softness for an immediate buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: clear price target lift cycle across the Street since mid-Nov 2025 into Jan 2026.
Most constructive calls: CIBC upgraded to Outperformer with PT C$58; BMO Outperform C$58; RBC Outperform C$52; TD Buy C$57; National Bank Outperform C$53.
More cautious voices: Barclays and Morgan Stanley remain Equal Weight, even while raising targets (suggesting “good company, but valuation/macro keeps them measured”).
Wall Street pros/cons summary:
- Pros: execution vs medium-term targets, capital strength/cash flow narrative, and Asia growth cited as supportive.
- Cons: rate/spread dynamics and tech spend can cap upside, aligning with the continued presence of Equal Weight ratings.

11 Analyst Rating

Wall Street analysts forecast MFC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MFC is 40.09 USD with a low forecast of 37.21 USD and a high forecast of 51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

2 Hold

0 Sell

Strong Buy

Current: 37.370

Low

37.21

Averages

40.09

High

Current: 37.370

Low

37.21

Averages

40.09

High

Scotiabank

Mike Rizvanovic

Outperform

maintain

$53 -> $55

AI Analysis

2026-02-05

New

Reason

Scotiabank

Mike Rizvanovic

Price Target

$53 -> $55

AI Analysis

2026-02-05

New

maintain

Outperform

Reason

Scotiabank analyst Mike Rizvanovic raised the firm's price target on Manulife Financial to C$55 from C$53 and keeps an Outperform rating on the shares.

Barclays

Equal Weight

maintain

$49 -> $52

2026-01-08

Reason

Barclays

Price Target

$49 -> $52

2026-01-08

maintain

Equal Weight

Reason

Barclays raised the firm's price target on Manulife Financial to C$52 from C$49 and keeps an Equal Weight rating on the shares. The firm is "cautiously optimistic" on life insurers heading into 2026, saying capital strength, cash flow, and consolidation offset headwinds like spread compression and technology spend. Barclays adjusted ratings and price targets as part of its 2026 outlook.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MFC

Unlock Now

MFC Should I Buy

MFC Should I Buy

Should You Buy Manulife Financial Corp (MFC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch